Rock-Springs-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "NUVL",
  "ASND",
  "INSM",
  "NAMS",
  "RVMD",
  "ARGX",
  "INSP",
  "ACHC",
  "EXAS",
  "MDGL",
  "APLS",
  "ALNY",
  "FOLD",
  "EVH",
  "BSX",
  "NVAX",
  "MREO",
  null,
  "BCAX",
  "GPCR",
  "CATX",
  "MIRM",
  "TVTX",
  "LENZ",
  "SMMT",
  "MLYS",
  "KYMR",
  "PHVS",
  "LEGN",
  "PRTA",
  "NGNE",
  "AGL",
  "AMLX",
  "JANX",
  "APLT",
  "SRRK",
  "OSCR",
  "ISRG",
  "TARS",
  "NBIX",
  "JSPR",
  "KRRO",
  "MGNX",
  "MRSN",
  null,
  "LUNG",
  "SGMT",
  null,
  "ZBIO",
  "EDAP",
  null,
  "ACRS",
  null,
  "UNH",
  "REGN",
  "AGIO",
  "ATEC",
  "PHR",
  "PLRX",
  "RYTM",
  "SLNO",
  "ADAP",
  "ETNB",
  "DYN",
  "ARDX",
  null,
  "SPRB",
  "GOSS",
  "EW",
  "SRPT",
  "PEN",
  "THC",
  "CGEN",
  "ELVN",
  "INZY",
  "VIGL",
  "WRBY",
  "WST",
  "XENE",
  "ZLAB",
  "VERA",
  "RARE",
  "IMVT",
  "IRTC",
  "AZTA",
  "BEAM",
  "BCRX",
  "BPMC",
  "CLDX",
  "CMPX",
  "CGEM",
  "DHR",
  "DXCM",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 96
Total Value: 1747790415
Accession Number: 0001172661-25-001953
Form Type: 13F-HR
CIK: rock-springs-capital-management-lp
Manager Name: Rock-Springs-Capital-Management-Lp

Data Enrichment

94% identified

90 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

96 positions • $1.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 5

Sort by:

AMICUS THERAPEUTICS, INC.

FOLD|03152W109

Shares:1.9M

Value:$15.6M

% of Portfolio:0.9% ($15.6M/$1.7B)

Warby Parker Inc.

WRBY|93403J106

Shares:835.0K

Value:$15.2M

% of Portfolio:0.9% ($15.2M/$1.7B)

Mereo BioPharma Group plc

MREO|589492107

Shares:6.7M

Value:$15.0M

% of Portfolio:0.9% ($15.0M/$1.7B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:812.7K

Value:$14.7M

% of Portfolio:0.8% ($14.7M/$1.7B)

Oscar Health, Inc.

OSCR|687793109

Shares:1.1M

Value:$13.8M

% of Portfolio:0.8% ($13.8M/$1.7B)

WEST PHARMACEUTICAL SERVICES INC

WST|955306105

Shares:60.3K

Value:$13.5M

% of Portfolio:0.8% ($13.5M/$1.7B)

Vera Therapeutics, Inc.

VERA|92337R101

Shares:520.8K

Value:$12.5M

% of Portfolio:0.7% ($12.5M/$1.7B)

DANAHER CORP /DE/

DHR|235851102

Shares:58.8K

Value:$12.1M

% of Portfolio:0.7% ($12.1M/$1.7B)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:536.1K

Value:$11.0M

% of Portfolio:0.6% ($11.0M/$1.7B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:159.3K

Value:$10.2M

% of Portfolio:0.6% ($10.2M/$1.7B)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:342.2K

Value:$10.0M

% of Portfolio:0.6% ($10.0M/$1.7B)

Pharvaris N.V.

PHVS|N69605108

Shares:623.4K

Value:$9.8M

% of Portfolio:0.6% ($9.8M/$1.7B)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:5.0M

Value:$9.4M

% of Portfolio:0.5% ($9.4M/$1.7B)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:465.9K

Value:$9.2M

% of Portfolio:0.5% ($9.2M/$1.7B)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:124.1K

Value:$8.9M

% of Portfolio:0.5% ($8.9M/$1.7B)

ARDELYX, INC.

ARDX|039697107

Shares:1.6M

Value:$7.9M

% of Portfolio:0.5% ($7.9M/$1.7B)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:5.0M

Value:$7.7M

% of Portfolio:0.4% ($7.7M/$1.7B)

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:878.7K

Value:$6.9M

% of Portfolio:0.4% ($6.9M/$1.7B)

89bio, Inc.

ETNB|282559103

Shares:844.4K

Value:$6.1M

% of Portfolio:0.4% ($6.1M/$1.7B)

PROTHENA CORP PUBLIC LTD CO

PRTA|G72800108

Shares:492.6K

Value:$6.1M

% of Portfolio:0.3% ($6.1M/$1.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
AMICUS THERAPEUTICS, INC.(FOLDcusip03152W109)	1.9M	QoQ -26.54% (-690.1K) YoY +65.64% (+756.7K)	All Managers (Combined)	$15.6M	0.9% ($15.6M/$1.7B)	QoQ -36.37% (-$8.9M) YoY +14.74% (+$2.0M)
Warby Parker Inc.(WRBYcusip93403J106)	835.0K	QoQ -9.23% (-85.0K) YoY -59.85% (-1.2M)	All Managers (Combined)	$15.2M	0.9% ($15.2M/$1.7B)	QoQ -31.65% (-$7.1M) YoY -46.22% (-$13.1M)
Mereo BioPharma Group plc(MREOcusip589492107)	6.7M	QoQ -30.36% (-2.9M) YoY -17.90% (-1.5M)	All Managers (Combined)	$15.0M	0.9% ($15.0M/$1.7B)	QoQ -55.23% (-$18.6M) YoY -44.02% (-$11.8M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	812.7K	QoQ -33.50% (-409.5K) YoY -40.77% (-559.5K)	All Managers (Combined)	$14.7M	0.8% ($14.7M/$1.7B)	QoQ -52.24% (-$16.1M) YoY -74.38% (-$42.8M)
Oscar Health, Inc.(OSCRcusip687793109)	1.1M	QoQ 0.00% (-0) YoY -50.23% (-1.1M)	All Managers (Combined)	$13.8M	0.8% ($13.8M/$1.7B)	QoQ -2.45% (-$346.5K) YoY -56.12% (-$17.6M)
WEST PHARMACEUTICAL SERVICES INC(WSTcusip955306105)	60.3K	QoQ -64.29% (-108.5K) YoY -56.10% (-77.0K)	All Managers (Combined)	$13.5M	0.8% ($13.5M/$1.7B)	QoQ -75.59% (-$41.8M) YoY -75.16% (-$40.8M)
Vera Therapeutics, Inc.(VERAcusip92337R101)	520.8K	QoQ +6.75% (-32.9K) YoY +52.65% (-179.6K)	All Managers (Combined)	$12.5M	0.7% ($12.5M/$1.7B)	QoQ -39.36% (-$8.1M) YoY -14.96% (-$2.2M)
DANAHER CORP /DE/(DHRcusip235851102)	58.8K	QoQ NEW(+58.8K) YoY NEW(+58.8K)	All Managers (Combined)	$12.1M	0.7% ($12.1M/$1.7B)	QoQ NEW(+$12.1M) YoY NEW(+$12.1M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	536.1K	QoQ -30.15% (-231.4K) YoY NEW(+536.1K)	All Managers (Combined)	$11.0M	0.6% ($11.0M/$1.7B)	QoQ -44.36% (-$8.8M) YoY NEW(+$11.0M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	159.3K	QoQ -48.19% (-148.2K) YoY -51.37% (-168.3K)	All Managers (Combined)	$10.2M	0.6% ($10.2M/$1.7B)	QoQ -72.80% (-$27.2M) YoY -76.02% (-$32.2M)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	342.2K	QoQ -27.36% (-128.9K) YoY -80.60% (-1.4M)	All Managers (Combined)	$10.0M	0.6% ($10.0M/$1.7B)	QoQ -35.23% (-$5.5M) YoY -80.56% (-$41.6M)
Pharvaris N.V.(PHVScusipN69605108)	623.4K	QoQ -19.57% (-151.7K) YoY -17.20% (-129.5K)	All Managers (Combined)	$9.8M	0.6% ($9.8M/$1.7B)	QoQ -34.13% (-$5.1M) YoY -43.75% (-$7.6M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	5.0M	QoQ -14.12% (-816.6K) YoY -9.99% (-550.8K)	All Managers (Combined)	$9.4M	0.5% ($9.4M/$1.7B)	QoQ +12.52% (-$1.0M) YoY -13.62% (-$1.5M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	465.9K	QoQ +8.70% (-37.3K) YoY +8.70% (+37.3K)	All Managers (Combined)	$9.2M	0.5% ($9.2M/$1.7B)	QoQ -4.92% (-$474.5K) YoY +21.61% (+$1.6M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	124.1K	QoQ 0.00% (+0) YoY NEW(+124.1K)	All Managers (Combined)	$8.9M	0.5% ($8.9M/$1.7B)	QoQ +58.95% (+$3.3M) YoY NEW(+$8.9M)
ARDELYX, INC.(ARDXcusip039697107)	1.6M	QoQ +9.65% (+141.3K) YoY NEW(+1.6M)	All Managers (Combined)	$7.9M	0.5% ($7.9M/$1.7B)	QoQ +6.19% (+$459.8K) YoY NEW(+$7.9M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	5.0M	QoQ -18.66% (-1.2M) YoY +83.26% (+2.3M)	All Managers (Combined)	$7.7M	0.4% ($7.7M/$1.7B)	QoQ -49.82% (-$7.7M) YoY +126.13% (+$4.3M)
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	878.7K	QoQ 0.00% (-0) YoY NEW(+878.7K)	All Managers (Combined)	$6.9M	0.4% ($6.9M/$1.7B)	QoQ -3.54% (-$254.8K) YoY NEW(+$6.9M)
89bio, Inc.(ETNBcusip282559103)	844.4K	QoQ +52.77% (+291.7K) YoY NEW(+844.4K)	All Managers (Combined)	$6.1M	0.4% ($6.1M/$1.7B)	QoQ +42.02% (+$1.8M) YoY NEW(+$6.1M)
PROTHENA CORP PUBLIC LTD CO(PRTAcusipG72800108)	492.6K	QoQ -23.58% (-152.0K) YoY -21.18% (-132.4K)	All Managers (Combined)	$6.1M	0.3% ($6.1M/$1.7B)	QoQ -31.71% (-$2.8M) YoY -60.62% (-$9.4M)